Although the virus can mediate tumor cell lysis and release TAAs to stimulate the activation of anti-tumor-specific immune response in the host, it is often not enough to induce sufficient tumor-specific CD8+ T cell immune response. This evidence concerns the gene CD8A and neoplasm.